Controversies of thrombophylaxis following knee arthroplasty surgery
| dc.contributor.author | Campbell, David | |
| dc.contributor.author | Smith, Paul | |
| dc.contributor.author | Lewis, Peter | |
| dc.contributor.author | Bruce, Warwick | |
| dc.date.accessioned | 2015-12-10T22:23:22Z | |
| dc.date.issued | 2010 | |
| dc.date.updated | 2016-02-24T10:41:53Z | |
| dc.identifier.issn | 1445-1433 | |
| dc.identifier.uri | http://hdl.handle.net/1885/52751 | |
| dc.publisher | Blackwell Publishing Ltd | |
| dc.source | ANZ Journal of Surgery | |
| dc.subject | Keywords: anticoagulant agent; antithrombocytic agent; chemoprophylaxis; human; knee arthroplasty; practice guideline; review; risk management; vein thrombosis; venous thromboembolism; Anticoagulants; Arthroplasty, Replacement, Knee; Chemoprevention; Humans; Platel | |
| dc.title | Controversies of thrombophylaxis following knee arthroplasty surgery | |
| dc.type | Journal article | |
| local.bibliographicCitation.issue | 6 | |
| local.bibliographicCitation.lastpage | 395 | |
| local.bibliographicCitation.startpage | 391 | |
| local.contributor.affiliation | Campbell, David, Wakefield Orthopaedic Clinic | |
| local.contributor.affiliation | Smith, Paul, College of Medicine, Biology and Environment, ANU | |
| local.contributor.affiliation | Lewis, Peter, Wakefield Orthopaedic Clinic | |
| local.contributor.affiliation | Bruce, Warwick, University of Sydney | |
| local.contributor.authoruid | Smith, Paul, u1496431 | |
| local.description.embargo | 2037-12-31 | |
| local.description.notes | Imported from ARIES | |
| local.identifier.absfor | 110314 - Orthopaedics | |
| local.identifier.ariespublication | u4201517xPUB254 | |
| local.identifier.citationvolume | 80 | |
| local.identifier.doi | 10.1111/j.1445-2197.2010.05306.x | |
| local.identifier.scopusID | 2-s2.0-77953099859 | |
| local.type.status | Published Version |